High levels of lnc-FANCI-2 and low levels of MCAM expression in cervical cancer patients correlate with improved survival, indicating that lnc-FANCI-2 plays a critical role in regulating RAS signaling to affect cervical cancer progression and patient outcomes. Here, MCAM is linked to cervical carcinoma.